[et_pb_section fb_built=”1″ custom_padding_last_edited=”off|desktop” _builder_version=”4.16″ background_color=”#26619A” custom_padding=”0px||0px||false|false” custom_padding_tablet=”24vh||2vh||false|false” background_color_gradient_direction_tablet=”360deg” background_color_gradient_stops_tablet=”#2b87da 49%|#29c4a9 79%” background_color_gradient_start_position_tablet=”49%” background_color_gradient_end_position_tablet=”79%” background_size_tablet=”cover” background_position_tablet=”center_right” background_position_phone=”center_right” locked=”off” collapsed=”off” global_colors_info=”{}”][et_pb_row column_structure=”2_5,3_5″ use_custom_gutter=”on” gutter_width=”1″ make_equal=”on” custom_padding_last_edited=”on|tablet” _builder_version=”4.16″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” width=”100%” max_width=”100%” custom_padding=”0px||0px|4%|false|false” custom_padding_tablet=”0px|||0%|false|false” custom_padding_phone=”” locked=”off” global_colors_info=”{}”][et_pb_column type=”2_5″ _builder_version=”4.16″ custom_padding=”30px||||false|false” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_ds_breadcrumbs module_class=”light” _builder_version=”4.5.1″ _module_preset=”default” locked=”on” global_colors_info=”{}”][\/et_pb_ds_breadcrumbs][et_pb_text _builder_version=”4.16″ header_font=”|700|||||||” header_font_size=”42px” header_line_height=”1.15em” background_layout=”dark” width=”80%” max_width=”520px” module_alignment=”center” custom_margin=”3em||20px||false|false” custom_margin_tablet=”3em||||false|false” custom_margin_phone=”” custom_margin_last_edited=”on|desktop” header_font_size_tablet=”34px” header_font_size_phone=”24px” header_font_size_last_edited=”on|desktop” module_alignment_tablet=”” module_alignment_phone=”” module_alignment_last_edited=”on|tablet” global_colors_info=”{}”]<\/p>\n
[\/et_pb_text][et_pb_text _builder_version=”4.16″ text_font_size=”24px” background_layout=”dark” width=”80%” max_width=”520px” module_alignment=”center” custom_margin=”||40px||false|false” custom_padding=”||||false|false” text_font_size_tablet=”20px” text_font_size_phone=”16px” text_font_size_last_edited=”on|desktop” global_colors_info=”{}”]Adding value to clinical research;
\nthe ASPREE project is in a unique position to lead multiple sub-studies, each investigating specific health issues affecting older adults.
\n[\/et_pb_text][\/et_pb_column][et_pb_column type=”3_5″ _builder_version=”4.16″ background_image=”https:\/\/aspree.org\/wp-content\/uploads\/sites\/3\/2021\/07\/055_Mobile_Labs_Study_Participants_352288.jpg” custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_code _builder_version=”4.16″ _module_preset=”default” height=”34em” height_tablet=”250px” height_phone=”250px” height_last_edited=”on|phone” global_colors_info=”{}”][\/et_pb_code][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ specialty=”on” padding_right_2=”0px” padding_left_2=”0px” padding_top_bottom_link_2=”false” padding_left_right_link_2=”true” module_class=”texture-left” _builder_version=”4.16″ _module_preset=”default” inner_max_width=”80%” custom_margin=”||||false|false” custom_padding=”||90px||false|false” border_color_bottom=”#bdbec0″ global_colors_info=”{}”][et_pb_column type=”1_3″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.16″ text_font=”|600|||||||” text_text_color=”#26619a” text_font_size=”32px” header_line_height=”2em” header_2_font=”|600|||||||” header_2_font_size=”32px” header_2_line_height=”2em” header_3_font=”||||||||” text_font_size_tablet=”28px” text_font_size_phone=”24px” text_font_size_last_edited=”on|phone” header_2_font_size_tablet=”28px” header_2_font_size_phone=”24px” header_2_font_size_last_edited=”on|phone” locked=”off” global_colors_info=”{}”]<\/p>\n
[\/et_pb_text][\/et_pb_column][et_pb_column type=”2_3″ specialty_columns=”2″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_row_inner admin_label=”PUT CONTENT BELOW AS A TEXT AND IMAGES” _builder_version=”4.16″ _module_preset=”default” max_width=”840px” custom_padding=”|0px||0px|true|true” global_colors_info=”{}”][et_pb_column_inner saved_specialty_column_type=”2_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n
A sub-study (also known as an ancillary study) is a type of \u2018add-on\u2019 study that answers a separate research question within a larger research project. Sub-studies research specific health questions that are not included in the main study. The ASPREE project is in a unique position to conduct multiple sub-studies. The extra health information will help show the interrelationships between various factors that can affect how we age.<\/p>\n
Sub-studies provide new opportunities and experiences for participants – from donating blood samples, to having hearing tests, retinal photographs, sleep apnoea checks, MRI scans, to completing additional questionnaires about lifestyle, diet and more.<\/p>\n
Not all ASPREE participants were able to enrol in all sub-studies because each sub-study was introduced at a different stage in the trial, when funding became available or special equipment was present at the time. \u00a0However, most participants volunteered for at least one sub-study during the ASPREE trial.\u00a0
Some sub-studies use existing medical health records and\u00a0do not require any additional participant activities.<\/p>\n
Thanks to the generosity of our study participants, these sub-studies provide invaluable information about aspirin, health and aging, that we would not otherwise be able to collect in the main research project.<\/p>\n
[\/et_pb_text][\/et_pb_column_inner][\/et_pb_row_inner][\/et_pb_column][\/et_pb_section][et_pb_section fb_built=”1″ specialty=”on” disabled_on=”off|off|off” admin_label=”TABBED CONTENT (LIGHT)” module_id=”scroll_tab1″ module_class=”tabs” _builder_version=”4.16″ _module_preset=”default” inner_max_width=”80%” custom_margin=”||||false|false” custom_padding=”||90px||false|false” border_width_bottom=”1px” border_color_bottom=”#bdbec0″ collapsed=”off” global_colors_info=”{}”][et_pb_column type=”1_3″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text admin_label=”TITLE” _builder_version=”4.16″ header_2_font=”|600|||||||” header_2_font_size=”32px” header_2_font_size_tablet=”28px” header_2_font_size_phone=”24px” header_2_font_size_last_edited=”on|desktop” locked=”off” global_colors_info=”{}”]<\/p>\n
Click on the sub-study below for more information ASPREE Cancer Treatment Study (ACTS)<\/a><\/p>\n [\/et_pb_text][et_pb_text admin_label=”ASPREE-D” module_class=”tab-link” _builder_version=”4.16″ _module_preset=”default” link_text_color=”#2F2F2F” custom_margin=”||20px||false|false” global_colors_info=”{}”]ASPREE-D (Depression)<\/a> [\/et_pb_text][et_pb_image src=”https:\/\/aspree.org\/wp-content\/uploads\/sites\/3\/2021\/07\/shutterstock_176899670-2-e1426572389378.jpg” title_text=”Blood and tumour samples will be analysed to determine the effect of aspirin on cancer in the ASPREE Cancer Endpoints Sub-study” _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][et_pb_text admin_label=”caption” _builder_version=”4.19.3″ _module_preset=”default” custom_padding=”0px|||||” locked=”off” global_colors_info=”{}”]<\/p>\n Above: An illustration of a cancer tissue sample in preparation for close examination by researchers<\/em><\/p>\n [\/et_pb_text][et_pb_text _builder_version=”4.19.3″ _module_preset=”default” text_text_color=”#000000″ global_colors_info=”{}”]<\/p>\n Summary<\/strong>: The ACES sub-study is funded by the National Cancer Institute (NCI), with the aim to understand factors associated with the development and spread of different types of cancers in older adults.<\/p>\n Cancer is one of the most common diseases and a leading cause of death worldwide. Aging is a factor that increases the risk of cancer.<\/span><\/p>\n ACES collects cancer related health information from participants annually and stores blood or saliva and cancer tissue samples (biospecimens) in a biorepository.<\/p>\n Aims:<\/strong> Research using these data may help predict what factors influence the incidence of specific cancers, their spread (metastasis) and the impact of a therapy (including low-dose aspirin) on cancer-free survival.<\/p>\n Health Information collected:<\/strong><\/p>\n Location:<\/strong>\u00a0USA and Australia<\/p>\n Status:<\/strong>\u00a0Active, not recruiting. Started in 2013, data collection continues<\/p>\n Additional Information:\u00a0 <\/strong>Participant\u00a0FAQs<\/a><\/p>\n Chief Investigator: <\/strong>Dr Suzanne Orchard<\/a><\/p>\n Publications: <\/strong>Yes<\/a><\/p>\n Collaborators:\u00a0<\/strong><\/p>\n Funding:<\/strong><\/p>\n Data Access: <\/strong>Contact the relevant sub-study chief investigator or visit the\u00a0ASPREE Access Management Site<\/a>\u00a0(AMS) before submitting an expression of interest to access sub-study data.\u00a0\u00a0<\/strong><\/p>\n Content updated: February 7, 2023<\/span><\/p>\n [\/et_pb_text][\/et_pb_column_inner][\/et_pb_row_inner][et_pb_row_inner admin_label=”ASPREE Cancer Treatment Study (ACTS)” module_class=”tab-content” _builder_version=”4.16″ _module_preset=”default” max_width=”840px” global_colors_info=”{}”][et_pb_column_inner saved_specialty_column_type=”2_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ header_2_font=”|600|||||||” header_2_font_size=”32px” header_2_font_size_tablet=”28px” header_2_font_size_phone=”24px” header_2_font_size_last_edited=”on|desktop” locked=”off” global_colors_info=”{}”]<\/p>\n [\/et_pb_text][et_pb_image src=”https:\/\/aspree.org\/wp-content\/uploads\/sites\/3\/2021\/07\/16277926.jpg” title_text=”16277926″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][et_pb_text admin_label=”Caption” _builder_version=”4.19.3″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n The ASPREE Cancer Treatment will determine whether surviving cancer increases the risk of persistent health problems for older adults.<\/em><\/p>\n [\/et_pb_text][et_pb_text _builder_version=”4.19.3″ _module_preset=”default” text_text_color=”#000000″ global_colors_info=”{}”]<\/p>\n Summary<\/strong>: Cancer is one of the most common diseases and a leading cause of death worldwide. Aging increases the risk of cancer.<\/span><\/p>\n Early detection and new treatments have generally increased cancer survival. Research suggests that cancer survivors are more likely to develop persistent health problems and experience more rapid declines in cognition (thinking and memory) and functional ability than similar-aged adults who have not had cancer. It is not well understood if these increased risks are due to cancer itself, or whether the treatment, overall, or specific treatment type, plays a role.<\/p>\n Aim:<\/strong> To determine whether surviving cancer increases the risk of persistent diseases, such as cardiovascular disease, cognitive health and physical function.<\/p>\n Health Information collected:<\/strong><\/p>\n Location:<\/strong>\u00a0USA and Australia<\/p>\n Status:<\/strong>\u00a0Active, not recruiting. Started in 2020, data collection continues<\/p>\n Chief Investigators: <\/strong>Prof John Zalcberg,\u00a0Dr Suzanne Orchard<\/a><\/p>\n Publications:\u00a0<\/strong>N\/A<\/span><\/p>\n Collaborators:\u00a0<\/strong><\/p>\n Funding:<\/strong><\/p>\n Data Access: <\/strong>Contact the relevant sub-study chief investigator or visit the\u00a0ASPREE Access Management Site<\/a>\u00a0(AMS) before submitting an expression of interest to access sub-study data.<\/p>\n Content updated: February 7, 2023<\/span><\/p>\n [\/et_pb_text][\/et_pb_column_inner][\/et_pb_row_inner][et_pb_row_inner admin_label=”ASPREE D” module_id=”scroll_tab2″ module_class=”tab-content” _builder_version=”4.16″ _module_preset=”default” max_width=”840px” global_colors_info=”{}”][et_pb_column_inner saved_specialty_column_type=”2_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ header_2_font=”|600|||||||” header_2_font_size=”32px” header_2_font_size_tablet=”28px” header_2_font_size_phone=”24px” header_2_font_size_last_edited=”on|desktop” locked=”off” global_colors_info=”{}”]<\/p>\n [\/et_pb_text][et_pb_image src=”https:\/\/aspree.org\/wp-content\/uploads\/sites\/3\/2021\/07\/halgatewood-com-uo7xJIV4Awk-unsplash.ed_.jpg” title_text=”halgatewood-com-uo7xJIV4Awk-unsplash.ed” _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][et_pb_text admin_label=”caption” _builder_version=”4.19.3″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n ASPREE-D was the first to study the effect of aspirin versus placebo on the prevention of depression in older adults.<\/em><\/p>\n [\/et_pb_text][et_pb_text _builder_version=”4.19.3″ _module_preset=”default” text_text_color=”#000000″ global_colors_info=”{}”]<\/p>\n <\/p>\n Summary: <\/strong>An estimated 10-15% of people aged between 70 \u2013 85 years will experience depression at some point in time. Symptoms of depression are often missed and untreated and can be mistakenly attributed to ageing and subsequently remain undetected and untreated. In older people, untreated depression is associated with a wide range of poor health outcomes, including an increased risk of dementia, social isolation, loss of quality of life and a shortened lifespan. Depression is associated with increased inflammation raising the question whether anti-inflammatory therapies might be useful for prevention or treatment of depression.<\/p>\n Aim: \u00a0<\/strong>Aspirin has well-known anti-inflammatory actions. With the large number of people enrolled in the ASPREE trial, for the first time, researchers in the ASPREE-D sub-study investigated whether aspirin prevented the onset of depression in older adults, or could alleviate depression in those presenting with depression.<\/p>\n Health Information Collected: <\/strong><\/p>\n Location:<\/strong>\u00a0USA and Australia<\/p>\n Status:<\/strong> Completed.\u00a0Main\u00a0findings published (with exception of the inflammatory biomarker component)<\/p>\n Chief Investigator:<\/strong> Prof Michael Berk<\/a><\/p>\n Publications:<\/strong> Yes<\/a><\/p>\n Collaborators:<\/strong><\/p>\n Funding:<\/strong><\/p>\n Data Access: <\/strong>Contact the relevant sub-study chief investigator or visit the\u00a0ASPREE Access Management Site<\/a>\u00a0(AMS) before submitting an expression of interest to access sub-study data.<\/p>\n Content updated: July 9, 2022<\/span><\/p>\n [\/et_pb_text][\/et_pb_column_inner][\/et_pb_row_inner][et_pb_row_inner admin_label=”ASPREE EWAS” module_id=”scroll_tab2″ module_class=”tab-content” _builder_version=”4.16″ _module_preset=”default” max_width=”840px” global_colors_info=”{}”][et_pb_column_inner saved_specialty_column_type=”2_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text admin_label=”Text” _builder_version=”4.16″ header_2_font=”|600|||||||” header_2_font_size=”32px” header_2_font_size_tablet=”28px” header_2_font_size_phone=”24px” header_2_font_size_last_edited=”on|desktop” locked=”off” global_colors_info=”{}”]<\/p>\n [\/et_pb_text][et_pb_image src=”https:\/\/aspree.org\/wp-content\/uploads\/sites\/3\/2021\/07\/DNA-Methylation_Fin_BGweb.jpg” title_text=”DNA Methylation_Fin_BGweb” _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][et_pb_text admin_label=”caption” _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”]Above: An illustration of a methylation (M) pattern on our genes. The top picture represents the gene acting normally, when we are in good health. Methyl groups can act as a ‘stop’ sign to genes associated with disease. In the lower image, the methyl groups are removed and the genes associated with a disease are switched ‘on’.\u00a0 <\/em><\/p>\n The EWAS sub-study will examine how lifestyle and environmental factors, such as nutrition, physical activity, pollution and stress may change DNA methylation to switch gene function ‘on’ or ‘off’ over time.\u00a0<\/em> <\/p>\n Summary:\u00a0<\/strong>We are all born with our own individual DNA or genetic code. The genetic code is the body\u2019s blueprint, containing all the necessary information for us to grow and function. Generally, our genetic code remains relatively fixed from conception until death. However additional information in our cells helps control how our genetic code is used over a lifetime, such as when the function of a gene is switched \u2018off\u2019 or \u2018on\u2019.<\/p>\n Lifestyle and environmental factors, such as nutrition, physical activity, pollution and stress may trigger one of several epigenetic processes which can activate or deactivate gene function.\u00a0 For instance, good nutrition may influence the production of chemicals (methylation) which attach to the genetic code and \u2018turn-off\u2019 genes associated with heart problems.\u00a0 This explains how a good diet may affect heart health at a genetic level.<\/p>\n Epigenetics is still a relatively new field and much more research is needed to understand how lifestyle behaviours such as increasing exercise may alter or reverse epigenetic patterns over the short and long term.<\/p>\n Epigenetic changes are also thought to underlie certain diseases. Some of the most widely studied mechanisms of epigenetic regulation include DNA methylation (the attachment of a chemical to the genome), histone modifications and non-coding RNAs. Due to its stability and ease of measurement, DNA methylation is most commonly examined in large studies involving many individuals.<\/p>\n This sub-study measures epigenome-wide DNA methylation patterns (EWAS) in blood samples donated by ASPREE participants at enrolment into the trial and three years later.<\/p>\n Researchers will examine 850,000 sites for biomarkers across all genes. The DNA methylation biomarkers can be matched with participants\u2019 lifestyle, behaviours and health at the time the sample was given, and prior to future health events, such as cancer or depression, should they occur.<\/p>\n The EWAS sub-study will enable researchers to use DNA methylation biomarkers to help identify older adults at risk of developing health conditions and help identify factors which may prevent or progress poor health.<\/p>\n Aims:\u00a0<\/strong><\/p>\n Health Information Collected: <\/strong><\/p>\n Location:<\/strong>\u00a0USA and Australia<\/p>\n Status: <\/strong>Active, not recruiting<\/p>\n Chief Investigator:<\/strong> A\/Prof Joanne Ryan<\/a><\/p>\n Publications: <\/strong>Yes<\/a><\/p>\n Collaborators:<\/strong><\/p>\n Funding:<\/strong><\/p>\n Data Access: <\/strong>Contact the relevant sub-study chief investigator or visit the\u00a0ASPREE Access Management Site<\/a>\u00a0(AMS) before submitting an expression of interest to access sub-study data.<\/p>\n Content updated: February 7, 2023<\/span><\/p>\n [\/et_pb_text][\/et_pb_column_inner][\/et_pb_row_inner][et_pb_row_inner admin_label=”GENOMICS” module_id=”scroll_tab2″ module_class=”tab-content” _builder_version=”4.16″ _module_preset=”default” max_width=”840px” global_colors_info=”{}”][et_pb_column_inner saved_specialty_column_type=”2_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ header_2_font=”|600|||||||” header_2_font_size=”32px” header_2_font_size_tablet=”28px” header_2_font_size_phone=”24px” header_2_font_size_last_edited=”on|desktop” locked=”off” global_colors_info=”{}”]<\/p>\n [\/et_pb_text][et_pb_image src=”https:\/\/aspree.org\/wp-content\/uploads\/sites\/3\/2021\/07\/aspree-G-1024×576-1.jpg” title_text=”aspree-G-1024×576″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][et_pb_text admin_label=”caption” _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”]Above: An illustration of the structure of DNA.<\/em> Summary:\u00a0<\/strong>Genetic research is a broad term for the study of traits passed down generations through the inheritance of genetic material (such as DNA). Genetic research has an important role in medical research.<\/span><\/p>\n Genes are the fundamental unit or \u2018blue-print\u2019 of life which can determine many of our physical traits such as eye colour and blood type. Genes also contribute, in combination with the environment, to more complex human traits such as personality, behaviour and the risk of developing a disease.<\/p>\n Humans have approximately 20,000 genes, each gene composed of a chemical called DNA (deoxyribonucleic acid). \u00a0DNA gives the instructions or the chemical code to express traits, such as telling the body which type of protein to make and when. \u00a0These proteins form part of a complex chain of events that impact on how we look and function.<\/p>\n Thanks to rapid advances in technology, an individual\u2019s entire genetic information can be studied through a process called genome sequencing. \u00a0Genome sequencing reveals more about human genetics than ever before; it also reveals large expanses of the human genome about which we know very little, if anything.<\/p>\n Our health often has at least a small genetic component. \u00a0Longevity that runs in families is an example of how genes may influence good health. Genetic research is in many ways, pioneering.\u00a0 Genetic research in older adults aims to understand the role genetic make-up has on our health so that one day we may be able to better detect or prevent age-related diseases such as cancer, dementia and cardiovascular disease.<\/p>\n Aims:<\/strong><\/p>\n Genetic studies on Biobank samples contribute to a growing body of research knowledge about genetics and health.\u00a0\u00a0 Samples in the\u00a0ASPREE Biobank\u00a0will enable researchers to better understand the role of our genes in health and ageing. Discoveries may take time to emerge, however their benefits and impact will be highly important for many years to come.<\/p>\n Health information collected<\/strong>:<\/p>\n Location:<\/strong>\u00a0USA and Australia<\/p>\n Chief Investigator:<\/strong> A\/Prof Paul Lacaze<\/a><\/p>\n Genomic projects:<\/strong><\/p>\n <\/p>\n 1.\u00a0 \u00a0The Medical Genome Reference Bank (MGRB) (Australia)<\/strong> \u2013 involves sequencing of 4,000 genomes from healthy people aged 75 years and over in the ASPREE study and the Sax Institute\u2019s \u201945 and Up\u2019 Study. Genetic information from the genomes will be used to form a reference bank or library of \u2018healthy genomes\u2019 of the \u2018wellderly\u2019 (well older people). The \u2018healthy\u2019 reference bank can be used as a comparison by researchers to identify, more easily, genes that cause disease.<\/p>\n Status:<\/strong>\u00a0Completed<\/p>\n <\/p>\n 2.\u00a0 \u00a0 The Resilience Project<\/strong> \u2013 examines approximately 760 genes from ASPREE Biobank participants in Australia and the US for the presence of genetic variations associated with disease. The aim is to identify and understand why healthy older adults with these genetic variations remain free of disease when others do not.\u00a0 Additionally, the Resilience Project may also help reveal to ASPREE researchers genes that can reliably predict the onset of cardiovascular disease, cancer, dementia and depression in older people.<\/p>\n Status:<\/strong>\u00a0Completed<\/p>\n <\/p>\n Publications: <\/strong>Yes<\/a><\/p>\n
\n[\/et_pb_text][et_pb_text admin_label=”ACES” module_class=”tab-link” _builder_version=”4.16″ _module_preset=”default” link_text_color=”#2F2F2F” custom_margin=”||20px||false|false” global_colors_info=”{}”]ASPREE Cancer Endpoints Study (ACES)<\/a>
\n[\/et_pb_text][et_pb_text admin_label=”ASPREE Cancer Treatment Study (ACTS)” module_class=”tab-link” _builder_version=”4.16″ _module_preset=”default” link_text_color=”#2F2F2F” custom_margin=”||20px||false|false” global_colors_info=”{}”]<\/p>\n
\n[\/et_pb_text][et_pb_text admin_label=”ASPREE-EWAS” module_class=”tab-link” _builder_version=”4.16″ _module_preset=”default” link_text_color=”#2F2F2F” custom_margin=”||20px||false|false” global_colors_info=”{}”]ASPREE-EWAS (Epigenetics)<\/a>
\n[\/et_pb_text][et_pb_text admin_label=”GENOMICS” module_class=”tab-link” _builder_version=”4.16″ _module_preset=”default” link_text_color=”#2F2F2F” custom_margin=”||20px||false|false” global_colors_info=”{}”]ASPREE-G (Genomics)<\/a>
\n[\/et_pb_text][et_pb_text admin_label=”ALSOP” module_class=”tab-link” _builder_version=”4.16″ _module_preset=”default” link_text_color=”#2F2F2F” custom_margin=”||20px||false|false” global_colors_info=”{}”]ASPREE Longitudinal Study of Older Persons (ALSOP)<\/a>
\n[\/et_pb_text][et_pb_text admin_label=”MICROBIOME” module_class=”tab-link” _builder_version=”4.20.4″ _module_preset=”default” link_text_color=”#2F2F2F” custom_margin=”||20px||false|false” global_colors_info=”{}”]ASPREE-XT Microbiome<\/a>[\/et_pb_text][\/et_pb_column][et_pb_column type=”2_3″ specialty_columns=”2″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_row_inner admin_label=”ACES” module_id=”scroll_tab2″ module_class=”tab-content” _builder_version=”4.16″ _module_preset=”default” max_width=”840px” global_colors_info=”{}”][et_pb_column_inner saved_specialty_column_type=”2_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ header_2_font=”|600|||||||” header_2_font_size=”32px” header_2_font_size_tablet=”28px” header_2_font_size_phone=”24px” header_2_font_size_last_edited=”on|desktop” locked=”off” global_colors_info=”{}”]<\/p>\nASPREE Cancer Endpoints Study (ACES)<\/h2>\n
A study of cancer in older adults<\/h3>\n
\n
\n
\n
ASPREE Cancer Treatment Study (ACTS)<\/h2>\n
A study of cancer treatment in older adults<\/h3>\n
\n
\n
\n
ASPREE-D (Depression)<\/h2>\n
A study of low-dose aspirin and depression in older adults<\/h3>\n
\n
\n
\n
ASPREE-EWAS (Epigenetics)<\/h2>\n
A study of blood DNA methylation in older adults<\/h3>\n
\n[\/et_pb_text][et_pb_text _builder_version=”4.19.3″ _module_preset=”default” text_text_color=”#000000″ global_colors_info=”{}”]<\/p>\n\n
\n
\n
\n
ASPREE-G (Genomics)<\/h2>\n
A study of genetics on the health of older adults<\/h3>\n
\n[\/et_pb_text][et_pb_text _builder_version=”4.20.4″ _module_preset=”default” text_text_color=”#000000″ global_colors_info=”{}”]<\/p>\n\n
\n\n
\n MGRB Collaborators:<\/strong><\/td>\n MGRB Funding:<\/strong><\/td>\n<\/tr>\n \n \n \n
\n \n
\n\n
\n The Resilience Project Collaborators:\u00a0<\/strong><\/td>\n The Resilience Project Funding:<\/strong><\/td>\n<\/tr>\n \n \n \n
\n \n